The use of isolated RBD molecules in inhibition ELISAs to detect nAbs has the disadvantage of excluding those nAbs generated in vaccinated COVID-19 patients or vaccinated individuals, that target the entire S protein trimer of SARS-CoV-2 or the S1 and S2 domains of the S protein. Here, PROS1 is linked to COVID-19.